Jane Street
CADX

Jane Street’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Jane Street’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,510
Closed -$149K – 3414
2013
Q4 		$149K Buy
+16,510
New +$119K ﹤0.01% 2104
2013
Q3 		– Sell
-23,659
Closed -$161K – 3523
2013
Q2 		$161K Buy
+23,659
New +$165K ﹤0.01% 2322

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jane Street's CADX Position: Q1 2014 in Review

Jane Street sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 16,510 shares — an estimated $149K sold.

Jane Street first reported a position in CADX in Q2 2013 and held it in 2 quarters. The position peaked at $161K in Q2 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Jane Street reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Jane Street sold 16,510 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $149K.
  • Jane Street first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 2 quarters.
  • Jane Street's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $161K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Jane Street's 13F filing for Q1 2014, filed 15 May 2014.